Ivan Chi Ho Au
About
Ivan Chi Ho Au is a scholar working on Infectious Diseases, Endocrinology, Diabetes and Metabolism and Surgery.
According to data from OpenAlex, Ivan Chi Ho Au has authored 41 papers receiving a total of 833 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Infectious Diseases, 12 papers in Endocrinology, Diabetes and Metabolism and 7 papers in Surgery. Recurrent topics in Ivan Chi Ho Au's work include SARS-CoV-2 and COVID-19 Research (20 papers), COVID-19 Clinical Research Studies (19 papers) and Diabetes Treatment and Management (9 papers). Ivan Chi Ho Au is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (20 papers), COVID-19 Clinical Research Studies (19 papers) and Diabetes Treatment and Management (9 papers). Ivan Chi Ho Au collaborates with scholars based in Hong Kong, United Kingdom and China. Ivan Chi Ho Au's co-authors include Carlos King Ho Wong, Kristy T. K. Lau, Benjamin J. Cowling, Eric H. Y. Lau, GM Leung, Xi Xiong, David Tak Wai Lui, Eric Ho Man Tang, Yu Cho Woo and Chi‐Ho Lee and has published in prestigious journals such as The Lancet, Nature Medicine and Nature Communications.
In The Last Decade
Ivan Chi Ho Au
38 papers receiving 821 citations
Hit Papers
Peers
Ivan Chi Ho Au
Kristy T. K. Lau Hong Kong
Nayla Cristina do Vale Moreira Belgium
Jessica Paola Bahena-López Mexico
Hassan Ismail Egypt
Ronen Arbel Israel
Yongli Zhang China
Shivam Khare India
Alejandro Márquez‐Salinas Mexico
Shrihari Anil Anikhindi India
Cunjin Wu China
Citations per year, relative to Ivan Chi Ho Au Ivan Chi Ho Au (= 1×)
peers
Kristy T. K. Lau
Countries citing papers authored by Ivan Chi Ho Au
Since
Specialization
Citations
This map shows the geographic impact of Ivan Chi Ho Au's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ivan Chi Ho Au with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ivan Chi Ho Au more than expected).
Fields of papers citing papers by Ivan Chi Ho Au
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Ivan Chi Ho Au. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ivan Chi Ho Au. The network helps show where Ivan Chi Ho Au may publish in the future.
Co-authorship network of co-authors of Ivan Chi Ho Au
This figure shows the co-authorship network connecting the top 25 collaborators of Ivan Chi Ho Au. A scholar is included among the top collaborators of Ivan Chi Ho Au based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ivan Chi Ho Au. Ivan Chi Ho Au is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Fung, Matrix Man Him, Eric Ho Man Tang, Tingting Wu, et al.. (2025). Developing a named entity framework for thyroid cancer staging and risk level classification using large language models. npj Digital Medicine. 8(1). 134–134.
2.
Lui, David Tak Wai, Xi Xiong, Ching‐Lung Cheung, et al.. (2024). Risks of incident major osteoporotic fractures following SARS-CoV-2 infection among older individuals: a population-based cohort study in Hong Kong. Journal of Bone and Mineral Research. 39(5). 551–560.
3.
Wong, Carlos King Ho, Kristy T. K. Lau, Ivan Chi Ho Au, Eric H. Y. Lau, & Benjamin J. Cowling. (2023). Comparison of Bivalent and Monovalent mRNA Vaccine Boosters. Clinical Infectious Diseases. 78(3). 633–636.
4.
Lui, David Tak Wai, Eric Ho Man Tang, Tingting Wu, et al.. (2023). Risks of stroke, its subtypes and atrial fibrillation associated with glucagon-like peptide 1 receptor agonists versus sodium-glucose cotransporter 2 inhibitors: a real-world population-based cohort study in Hong Kong. Cardiovascular Diabetology. 22(1). 40–40.
5.
Wong, Carlos King Ho, Kristy T. K. Lau, Ivan Chi Ho Au, et al.. (2023). Viral burden rebound in hospitalised patients with COVID-19 receiving oral antivirals in Hong Kong: a population-wide retrospective cohort study. The Lancet Infectious Diseases. 23(6). 683–695.
6.
Xiong, Xi, David Tak Wai Lui, Ivan Chi Ho Au, et al.. (2023). Incidence of diabetes following COVID-19 vaccination and SARS-CoV-2 infection in Hong Kong: A population-based cohort study. PLoS Medicine. 20(7). e1004274–e1004274.
7.
Lui, David Tak Wai, Tingting Wu, Eric Ho Man Tang, et al.. (2023). Fracture risks associated with sodium-glucose cotransporter-2 inhibitors in type 2 diabetes patients across eGFR and albuminuria categories: A population-based study in Hong Kong. Diabetes Research and Clinical Practice. 197. 110576–110576.
8.
Wong, Carlos King Ho, Ivan Chi Ho Au, Kristy T. K. Lau, et al.. (2023). Optimal timing of nirmatrelvir/ritonavir treatment after COVID-19 symptom onset or diagnosis: target trial emulation. Nature Communications. 14(1). 8377–8377.
9.
Wong, Carlos King Ho, Xi Xiong, Kristy T. K. Lau, et al.. (2022). Impact of a delayed second dose of mRNA vaccine (BNT162b2) and inactivated SARS-CoV-2 vaccine (CoronaVac) on risks of all-cause mortality, emergency department visit, and unscheduled hospitalization. BMC Medicine. 20(1). 119–119.
10.
Lui, David Tak Wai, Ivan Chi Ho Au, Eric Ho Man Tang, et al.. (2022). Kidney outcomes associated with sodium-glucose cotransporter 2 inhibitors versus glucagon-like peptide 1 receptor agonists: A real-world population-based analysis. EClinicalMedicine. 50. 101510–101510.
11.
Lui, David Tak Wai, Eric Ho Man Tang, Ivan Chi Ho Au, et al.. (2022). Evaluation of Fracture Risk Among Patients With Type 2 Diabetes and Nonvalvular Atrial Fibrillation Receiving Different Oral Anticoagulants. Diabetes Care. 45(11). 2620–2627.
12.
Lui, David Tak Wai, Tingting Wu, Ivan Chi Ho Au, et al.. (2022). A Population-Based Study of SGLT2 Inhibitor-Associated Postoperative Diabetic Ketoacidosis in Patients with Type 2 Diabetes. Drug Safety. 46(1). 53–64.
13.
Wong, Carlos King Ho, David Tak Wai Lui, Xi Xiong, et al.. (2022). Risk of thyroid dysfunction associated with mRNA and inactivated COVID-19 vaccines: a population-based study of 2.3 million vaccine recipients. BMC Medicine. 20(1). 339–339.
14.
Wong, Carlos King Ho, Kristy T. K. Lau, Eric Ho Man Tang, et al.. (2022). Cardiovascular benefits of SGLT2 inhibitors in type 2 diabetes, interaction with metformin and role of erythrocytosis: a self-controlled case series study. Cardiovascular Diabetology. 21(1). 92–92.
15.
Xiong, Xi, Carlos King Ho Wong, Ivan Chi Ho Au, et al.. (2022). Safety of Inactivated and mRNA COVID-19 Vaccination Among Patients Treated for Hypothyroidism: A Population-Based Cohort Study. Thyroid. 32(5). 505–514.
16.
Wong, Carlos King Ho, Kristy T. K. Lau, Xi Xiong, et al.. (2022). Adverse events of special interest and mortality following vaccination with mRNA (BNT162b2) and inactivated (CoronaVac) SARS-CoV-2 vaccines in Hong Kong: A retrospective study. PLoS Medicine. 19(6). e1004018–e1004018.
17.
Wu, Tingting, Carlos King Ho Wong, Eric Ho Man Tang, et al.. (2022). The comparative effects of metabolic surgery, SGLT2i, or GLP-1RA in patients with obesity and type 2 diabetes: a retrospective cohort study. Surgery for Obesity and Related Diseases. 18(6). 762–771.
18.
Wong, Carlos King Ho, Ivan Chi Ho Au, Kristy T. K. Lau, et al.. (2022). Real-world effectiveness of early molnupiravir or nirmatrelvir–ritonavir in hospitalised patients with COVID-19 without supplemental oxygen requirement on admission during Hong Kong's omicron BA.2 wave: a retrospective cohort study. The Lancet Infectious Diseases. 22(12). 1681–1693.
19.
Wong, Carlos King Ho, Kristy T. K. Lau, Ivan Chi Ho Au, et al.. (2022). Initiation of Tocilizumab or Baricitinib Were Associated With Comparable Clinical Outcomes Among Patients Hospitalized With COVID-19 and Treated With Dexamethasone. Frontiers in Pharmacology. 13. 866441–866441.
20.
Wong, Carlos King Ho, Janet Yuen Ha Wong, Eric Ho Man Tang, et al.. (2020). Impact of National Containment Measures on Decelerating the Increase in Daily New Cases of COVID-19 in 54 Countries and 4 Epicenters of the Pandemic: Comparative Observational Study. Journal of Medical Internet Research. 22(7). e19904–e19904.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Kristy T. K. Lau Breakdown of academic impact, for papers by Nayla Cristina do Vale Moreira Breakdown of academic impact, for papers by Jessica Paola Bahena-López Breakdown of academic impact, for papers by Hassan Ismail Breakdown of academic impact, for papers by Ronen Arbel Breakdown of academic impact, for papers by Yongli Zhang Breakdown of academic impact, for papers by Shivam Khare Breakdown of academic impact, for papers by Alejandro Márquez‐Salinas Breakdown of academic impact, for papers by Shrihari Anil Anikhindi Breakdown of academic impact, for papers by Cunjin Wu